[1] Urban-Kowalczyk M, Pigonska J,? migielski J. Pain perception in schizophrenia: Influence of neuropeptides, cognitive disorders, and negative symptoms[J]. Neuropsychiatr Dis Treat, 2015,11:2023-2031.
[2] Kishi T,Ikuta T,Matsunaga S,et al. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: A network meta-analysis in a japanese population[J]. Neuropsychiatr Dis Treat,2017,13:1281-1302.
[3] Rogoz Z. Effect of combined treatment with mirtazapine and risperidone on the mk-801-induced changes in the object recognition test in mice[J]. Pharmacol Rep, 2013,65(5):1401-1406.
[4] Savitz AJ,Xu H,Gopal S,et al. Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: Subgroup analysis of a global, randomized, double-blind, phase iii, noninferiority study[J]. Neuropsychiatr Dis Treat,2017,13:2193-2207.
[5] Huang M,Yu L,Pan F,et al. A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients[J]. Prog Neuropsychopharmacol Biol Psychiatry,2018,81:122-130.
[6] Zhu D,Wang H,Wu J,et al. Postnatal administration of dizocilpine inhibits neuronal excitability in pfc and induces social deficits detected by miceprofiler[J]. Mol Neurobiol,2017,54(10):8152-8161.
[7] Mines MA,Yuskaitis CJ,King MK,et al. Gsk3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile x syndrome and autism[J]. PLoS One,2010,5(3):e9706.
[8] Wang JR,Sun PH,Ren ZX,et al. Gsk-3beta interacts with dopamine d1 receptor to regulate receptor function: Implication for prefrontal cortical d1 receptor dysfunction in schizophrenia[J]. CNS Neurosci Ther,2017,23(2):174-187.
[9] Park SJ,Lee Y,Oh HK,et al. Oleanolic acid attenuates mk-801-induced schizophrenia-like behaviors in mice[J]. Neuropharmacology,2014,86:49-56.
[10]Yu J,Qi D,Xing M,et al. Mk-801 induces schizophrenic behaviors through downregulating wnt signaling pathways in male mice[J]. Brain Res,2011,1385:281-292.
[11]MacDowell KS,Munarriz-Cuezva E,Caso JR,et al. Paliperidone reverts toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia[J]. Neuropharmacology,2017,116:196-207.
[12]Sun F,Su Z,Sui C,et al. Studies on the acute toxicity, pharmacokinetics and pharmacodynamics of paliperidone derivatives--comparison to paliperidone and risperidone in mice and rats[J]. Basic Clin Pharmacol Toxicol,2010,107(2):656-662.
[13]Kanchanatawan B,Thika S,Anderson G,et al. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition[J]. Prog Neuropsychopharmacol Biol Psychiatry,2018,80(Pt C):168-176.
[14]Deiana S,Watanabe A,Yamasaki Y,et al. Mk-801-induced deficits in social recognition in rats: Reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol[J]. Behav Pharmacol,2015,26(8 Spec No):748-765.
[15]Tuplin EW,Holahan MR. Aripiprazole, a drug that displays partial agonism and functional selectivity[J]. Curr Neuropharmacol,2017,15(8):1192-1207.
[16]Kaminska K,Rogoz Z. The effect of combined treatment with risperidone and antidepressants on the mk-801-induced deficits in the social interaction test in rats[J]. Pharmacol Rep,2015,67(6):1183-1187.
[17]Jeon SJ,Kim E,Lee JS,et al. Maslinic acid ameliorates nmda receptor blockade-induced schizophrenia-like behaviors in mice[J]. Neuropharmacology, 2017,126:168-178.
[18]Hasan A,Falkai P,Wobrock T,et al. World federation of societies of biological psychiatry (wfsbp) guidelines for biological treatment of schizophrenia. Part 3: Update 2015 management of special circumstances: Depression, suicidality, substance use disorders and pregnancy and lactation[J]. World J Biol Psychiatry, 2015,16(3):142-170.
[19]Mauri MC,Reggiori A,Paletta S,et al. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation[J]. Expert Opin Drug Saf,2017,16(3):365-379.
[20]Damkier P,Videbech P. The safety of second-generation antipsychotics during pregnancy: A clinically focused review[J]. CNS Drugs,2018,32(4):351-366.
[21]Nakagawa R,Ohnishi T,Kobayashi H,et al. The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia[J]. Neuropsychiatr Dis Treat,2015,11:1511-1521.
[22]Tsugawa S,Nakajima SL. [to test glutamate hypothesis for schizophrenia utilizing proton magnetic resonance spectroscopy] [J]. Brain Nerve,2017,69(9):1035-1040.
[23]Lefevre EM,Eyles DW,Burne TH. Behavioural sensitisation to mk-801 is dose-dependent and independent of environmental context[J]. Behav Brain Res,2016,298(Pt B):241-245.
[24]Wu H,Wang X,Gao Y,et al. NMDA receptor antagonism by repetitive mk801 administration induces schizophrenia-like structural changes in the rat brain as revealed by voxel-based morphometry and diffusion tensor imaging[J]. Neuroscience,2016,322:221-233.
[25]Chang HY,Tseng PT,Stubbs B,et al. The efficacy and tolerability of paliperidone in mania of bipolar disorder: A preliminary meta-analysis[J]. Exp Clin Psychopharmacol,2017,25(5):422-433.
[26]Richtand NM,Ahlbrand R,Horn P,et al. Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation[J]. J Psychiatr Res,2011,45(9):1194-1201.
[27]Green MF,Horan WP,Lee J. Social cognition in schizophrenia[J]. Nat Rev Neurosci,2015,16(10):620-631.
[28]de Chaumont F,Coura RD,Serreau P,et al. Computerized video analysis of social interactions in mice[J]. Nat Methods,2012,9(4):410-417.
[29]Bicks LK,Koike H,Akbarian S,et al. Prefrontal cortex and social cognition in mouse and man[J]. Front Psychol,2015,6:1805.
[30]Wang F,Zhu J,Zhu H,et al. Bidirectional control of social hierarchy by synaptic efficacy in medial prefrontal cortex[J]. Science,2011,334(6056):693-697.
[31]Prabhu VV,Nguyen TB,Cui Y,et al. Effects of social defeat stress on dopamine d2 receptor isoforms and proteins involved in intracellular trafficking[J]. Behav Brain Funct,2018,14(1):16.
[32]Abuelezz SA,Hendawy N,Magdy Y. The potential benefit of combined versus monotherapy of coenzyme q10 and fluoxetine on depressive-like behaviors and intermediates coupled to gsk-3beta in rats[J]. Toxicol Appl Pharmacol,2018,340:39-48.
[33]Schilbach L,Derntl B,Aleman A,et al. Differential patterns of dysconnectivity in mirror neuron and mentalizing networks in schizophrenia[J]. Schizophr Bull, 2016,42(5):1135-1148.
[34]Preller KH,Schilbach L,Pokorny T,et al. Role of the 5-ht2a receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: A pharmacological fmri study[J]. J Neurosci,2018,38(14):3603-3611.
[35]Polter AM,Li X. Glycogen synthase kinase-3 is an intermediate modulator of serotonin neurotransmission[J]. Front Mol Neurosci, 2011,4:31.
[36]Emamian ES,Hall D,Birnbaum MJ,et al. Convergent evidence for impaired akt1-gsk3beta signaling in schizophrenia[J]. Nat Genet,2004,36(2):131-137.
[37]Urbanska M,Gozdz A,Macias M,et al. Gsk3beta controls mtor and prosurvival signaling in neurons[J]. Mol Neurobiol,2017,55(7):6050-6062.
[38]Latapy C,Rioux V,Guitton MJ,et al. Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour[J]. Philos Trans R Soc Lond B Biol Sci,2012,367(1601):2460-2474.